ImageneBio (IMA) Change in Account Payables (2020 - 2024)

Historic Change in Account Payables for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to $1.1 million.

  • ImageneBio's Change in Account Payables rose 15666.49% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.2 million, marking a year-over-year increase of 5926.83%. This contributed to the annual value of -$1.2 million for FY2024, which is 5926.83% up from last year.
  • Per ImageneBio's latest filing, its Change in Account Payables stood at $1.1 million for Q4 2024, which was up 15666.49% from -$1.6 million recorded in Q3 2024.
  • ImageneBio's 5-year Change in Account Payables high stood at $1.1 million for Q4 2024, and its period low was -$1.9 million during Q4 2023.
  • For the 5-year period, ImageneBio's Change in Account Payables averaged around -$172500.0, with its median value being -$40500.0 (2022).
  • Within the past 5 years, the most significant YoY rise in ImageneBio's Change in Account Payables was 1655000.0% (2023), while the steepest drop was 211529.41% (2023).
  • Over the past 5 years, ImageneBio's Change in Account Payables (Quarter) stood at $430000.0 in 2020, then grew by 5.81% to $455000.0 in 2021, then tumbled by 118.68% to -$85000.0 in 2022, then plummeted by 2115.29% to -$1.9 million in 2023, then skyrocketed by 156.66% to $1.1 million in 2024.
  • Its Change in Account Payables was $1.1 million in Q4 2024, compared to -$1.6 million in Q3 2024 and -$501000.0 in Q2 2024.